Compare ALKT & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKT | NEOG |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2021 | 1995 |
| Metric | ALKT | NEOG |
|---|---|---|
| Price | $20.22 | $11.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $28.57 | $10.67 |
| AVG Volume (30 Days) | 1.3M | ★ 2.1M |
| Earning Date | 04-29-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.20 |
| EPS | N/A | ★ N/A |
| Revenue | $152,159,000.00 | ★ $870,400,000.00 |
| Revenue This Year | $21.85 | N/A |
| Revenue Next Year | $16.90 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 35.68 | N/A |
| 52 Week Low | $13.98 | $4.90 |
| 52 Week High | $26.89 | $12.85 |
| Indicator | ALKT | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 62.47 | 55.97 |
| Support Level | $19.60 | $8.86 |
| Resistance Level | $21.05 | $12.26 |
| Average True Range (ATR) | 0.63 | 0.40 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 59.43 | 32.98 |
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.